Announcements

/Announcements

August 2017

Interpace Diagnostics Announces Coverage of Thyroid Test by Oxford Health Plans

PARSIPPANY, N.J., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) [...]

Interpace Diagnostics Group Reports Second Quarter 2017 Financial Results, Business Progress and Recent Accomplishments

Aug 10, 2017 (GLOBE NEWSWIRE via COMTEX) -- Net Revenue Grew 7% Over [...]

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on Thursday August 10, 2017

PARSIPPANY, N.J., Aug 09, 2017 (GLOBE NEWSWIRE via COMTEX) -- Interpace Diagnostics Group, [...]

Interpace Diagnostics Launches Product Extension at World Conference on Thyroid Cancer

Expansion of ThyGenX(R) Panel Provides Additional Molecular Insights BOSTON, Aug 01, 2017 (GLOBE [...]

July 2017

Interpace Diagnostics Announces Cigna Coverage of ThyGenX(R)

Molecular Test Now Covered for Indeterminate Thyroid Nodules PARSIPPANY, N.J., Jul 27, 2017 [...]

Interpace Diagnostics Joins the Fight Against Pancreatic Cancer at the Pittsburgh PurpleStride Event

The Pancreatic Cancer Action Network's PurpleStride Events Raise Funds and Awareness for the [...]

June 2017

Interpace Diagnostics Announces National Contract with Aetna

New Agreement Covers Thyroid Products ThyGenX(R) and ThyraMIR(R) PARSIPPANY, N.J., Jun 28, 2017 [...]

Interpace Diagnostics Announces Coverage of Thyroid Test By Premera Blue Cross

Northwest's Largest Regional Health Plan Adds Coverage for ThyraMIR(R) PARSIPPANY, N.J., Jun 26, [...]

Interpace Diagnostics Announces Closing of $13.7 Million Public Offering

PARSIPPANY, N.J., Jun 21, 2017 (GLOBE NEWSWIRE via COMTEX) -- Interpace Diagnostics Group, [...]

Interpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants

PARSIPPANY, N.J., Jun 16, 2017 (GLOBE NEWSWIRE via COMTEX) -- Interpace Diagnostics Group, [...]